Cargando…

Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach

Obsessive-Compulsive Disorder (OCD) is one of the most common mental conditions. Proteome profiling may help identifying important proteins and finally shed lights to complexity of OCD underlying mechanisms. Here, by the application gel-based proteomic approach the proteome profile of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamanian Azodi, Mona, Rezaei Tavirani, Mostafa, Arefi Oskouie, Afsaneh, Hamdieh, Mostafa, Derakhshan, Mohammad Kamran, Ahmadzadeh, Alireza, Zayeri, Farid, Nejadi, Naser, Rezaei Tavirani, Majid, Mansouri, Vahid, Rostami-Nejad, Mohammad, Vafaee, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610783/
https://www.ncbi.nlm.nih.gov/pubmed/29201116
_version_ 1783265823207456768
author Zamanian Azodi, Mona
Rezaei Tavirani, Mostafa
Arefi Oskouie, Afsaneh
Hamdieh, Mostafa
Derakhshan, Mohammad Kamran
Ahmadzadeh, Alireza
Zayeri, Farid
Nejadi, Naser
Rezaei Tavirani, Majid
Mansouri, Vahid
Rostami-Nejad, Mohammad
Vafaee, Reza
author_facet Zamanian Azodi, Mona
Rezaei Tavirani, Mostafa
Arefi Oskouie, Afsaneh
Hamdieh, Mostafa
Derakhshan, Mohammad Kamran
Ahmadzadeh, Alireza
Zayeri, Farid
Nejadi, Naser
Rezaei Tavirani, Majid
Mansouri, Vahid
Rostami-Nejad, Mohammad
Vafaee, Reza
author_sort Zamanian Azodi, Mona
collection PubMed
description Obsessive-Compulsive Disorder (OCD) is one of the most common mental conditions. Proteome profiling may help identifying important proteins and finally shed lights to complexity of OCD underlying mechanisms. Here, by the application gel-based proteomic approach the proteome profile of patients with washing subtype of OCD before and after treatment with Fluoxetine (positive responders) are compared to healthy matched controls. However, only one of the differentially expressed proteins is examined and introduced in this paper. Proteomic analysis was done by the application of two-dimensional polyacrylamide gel electrophoresis (2-D PAGE), combined with (MALDI-TOF-TOF MS)-based. Furthermore, network analysis and biological annotation were handled by Cytoscape Plug-in and CluePedia. The proteome comparison between groups identified protein with the significant expression changes (p<0.05 and fold change ≥ 1.5). While the expression level of Ig Kappa Chain C Region is significantly decreased in OCD patients before any treatments, the trend is almost normalized after treatment with Fluoxetine in positive responders. In addition, interaction profile of IGKC shows that the interacting proteins may be affected as the expression pattern of IGKC changes in OCD patients. In conclusion, IGKC may be introduced as potential biomarker in our study; yet, investigation in bigger sample size and application of validation methods is a requirement.
format Online
Article
Text
id pubmed-5610783
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-56107832017-12-01 Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach Zamanian Azodi, Mona Rezaei Tavirani, Mostafa Arefi Oskouie, Afsaneh Hamdieh, Mostafa Derakhshan, Mohammad Kamran Ahmadzadeh, Alireza Zayeri, Farid Nejadi, Naser Rezaei Tavirani, Majid Mansouri, Vahid Rostami-Nejad, Mohammad Vafaee, Reza Iran J Pharm Res Original Article Obsessive-Compulsive Disorder (OCD) is one of the most common mental conditions. Proteome profiling may help identifying important proteins and finally shed lights to complexity of OCD underlying mechanisms. Here, by the application gel-based proteomic approach the proteome profile of patients with washing subtype of OCD before and after treatment with Fluoxetine (positive responders) are compared to healthy matched controls. However, only one of the differentially expressed proteins is examined and introduced in this paper. Proteomic analysis was done by the application of two-dimensional polyacrylamide gel electrophoresis (2-D PAGE), combined with (MALDI-TOF-TOF MS)-based. Furthermore, network analysis and biological annotation were handled by Cytoscape Plug-in and CluePedia. The proteome comparison between groups identified protein with the significant expression changes (p<0.05 and fold change ≥ 1.5). While the expression level of Ig Kappa Chain C Region is significantly decreased in OCD patients before any treatments, the trend is almost normalized after treatment with Fluoxetine in positive responders. In addition, interaction profile of IGKC shows that the interacting proteins may be affected as the expression pattern of IGKC changes in OCD patients. In conclusion, IGKC may be introduced as potential biomarker in our study; yet, investigation in bigger sample size and application of validation methods is a requirement. Shaheed Beheshti University of Medical Sciences 2017 /pmc/articles/PMC5610783/ /pubmed/29201116 Text en © 2017 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Zamanian Azodi, Mona
Rezaei Tavirani, Mostafa
Arefi Oskouie, Afsaneh
Hamdieh, Mostafa
Derakhshan, Mohammad Kamran
Ahmadzadeh, Alireza
Zayeri, Farid
Nejadi, Naser
Rezaei Tavirani, Majid
Mansouri, Vahid
Rostami-Nejad, Mohammad
Vafaee, Reza
Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach
title Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach
title_full Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach
title_fullStr Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach
title_full_unstemmed Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach
title_short Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach
title_sort fluoxetine regulates ig kappa chain c region expression levels in the serum of obsessive-compulsive disorder patients: a proteomic approach
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610783/
https://www.ncbi.nlm.nih.gov/pubmed/29201116
work_keys_str_mv AT zamanianazodimona fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT rezaeitaviranimostafa fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT arefioskouieafsaneh fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT hamdiehmostafa fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT derakhshanmohammadkamran fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT ahmadzadehalireza fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT zayerifarid fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT nejadinaser fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT rezaeitaviranimajid fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT mansourivahid fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT rostaminejadmohammad fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach
AT vafaeereza fluoxetineregulatesigkappachaincregionexpressionlevelsintheserumofobsessivecompulsivedisorderpatientsaproteomicapproach